〔Abstract〕 Objective To explore the clinical efficacy and psychological impact of aromatherapy massage combined with umbilical acupuncture on patients with anxiety-induced insomnia (Heart-kidney imbalance syndrome). Methods The subjects were 88 cases of anxiety-induced insomnia (Heart-kidney imbalance type) from August 2022 to October 2023 in the Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine. They were randomly divided into two groups, with 3 patients dropping out, resulting in 43 cases in the control group and 42 cases in the observation group. The control group received oral estazolam, while the observation group was treated with aromatherapy massage combined with umbilical acupuncture. Serum dopamine (DA) and 5-hydroxytryptamine (5-HT) levels were measured before and after treatment. The Pittsburgh sleep quality index (PSQI), Hamilton anxicty scale (HAMA), and Traditional Chinese Medicine (TCM) syndrome scores were used as outcome measures to compare the efficacy and adverse event rates between the two groups. Results After treatment, the serum levels of DA and 5-HT in the observation group were higher than those in the control group; the scores of PSQI and HAMA in the observation group were lower than those in the control group; the TCM syndrome scores for primary, secondary, and total symptoms in the observation group were lower than those in the control group; the total effective rate in the observation group was 85.71%, higher than the 74.42% in the control group. All these differences were statistically significant (P < 0.05). There was no statistically significant difference in the adverse reaction rate between the two groups (P > 0.05). Conclusion Aromatherapy massage combined with umbilical acupuncture is effective and reliable in the clinical treatment of anxiety-induced insomnia patients with Heart-kidney imbalance syndrome. It has similar safety to traditional medications and can improve sleep and psychological status. Its mechanism of action is related to the regulation of serum neurotransmitters associated with mood.